Europe Proton Therapy Market Industry Trends and Forecast to 2034: Segmented by (Product, System, Cancer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Europe · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$231.3 MnPlaceholder estimate
Estimate 2025$249.6 Mn17.5% of the global market
Projected 2034$494.8 Mn 98.2%Adds $245.2 Mn over 9 forecast years
CAGR 2025–20347.9%Faster than 52% of 173 Medical Devices markets here
Key players5
Europe is 17.51% of the global market.
Among regions, the largest is North America at $630.3 Mn.
38 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Europe Proton Therapy Market Analysis Executive Summary
Proton therapy is a type of radiation therapy that uses protons to target tumours more precisely and spare healthy tissue.
Key segments of the proton Therapy market include product (Proton Therapy Systems and Services), system (Single-Room Systems and Multi-Room Systems) and cancer (Pediatric Cancers, Brain and CNS and Head and Neck).
Europe Proton Therapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Europe Proton Therapy Market Dynamics
Market Growth Drivers
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the proton Therapy market. Faster approvals and new combinations are improving survival.
Opportunity
Biomarker-led treatment, earlier lines of therapy and expansion into emerging markets offer strong growth for the proton Therapy market.
Market Restraints
High treatment costs, drug resistance, side effects and unequal access to cancer centres hold back the proton Therapy market, especially in low- and middle-income countries.
Competitive Landscape for Proton Therapy Market in Europe
The proton Therapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Proton Therapy Market in Europe
Proton Therapy in Europe: rules, payment and research
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.[1] In the countries we cover here, medical devices are regulated by ANSM (France)[2], BfArM (Germany)[3], Ministry of Health (Italy)[4], Roszdravnadzor (Russia)[5], AEMPS (Spain)[6] and MHRA (UK)[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[8] ClinicalTrials.gov lists 38 studies on Proton Therapy that are recruiting, active or about to start in Europe.[9]
[9]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how proton Therapy products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Product
4.2 By System
4.3 By Cancer
4.4 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 IBA (Ion Beam Applications)
7.2 Varian (Siemens Healthineers)
7.3 Hitachi
7.4 Mevion Medical Systems
7.5 Sumitomo Heavy Industries
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The proton Therapy market can be segmented based on various criteria, including product, system, cancer and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: FDA 510(k) and PMA databases, 510(k) clearances and PMA approvals since 2015 for devices whose name has this market's words. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Proton Therapy right now, from free public sources.
Clinical trials
38 active trials in UK, Germany, France, Italy, Spain and Russia
Recruiting, about to start, or running now. Counted across the 6 countries we report on in Europe.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov.
Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Placeholder estimate: about $249.6 Mn in 2025, rising to about $494.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Proton Therapy market in Europe growing?
Placeholder estimate: about 7.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Proton Therapy market report cover?
The report splits the market by product (Proton Therapy Systems, Services), system (Single-Room Systems, Multi-Room Systems), cancer (Pediatric Cancers, Brain and CNS, Head and Neck, Prostate) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Proton Therapy market?
Key players include IBA (Ion Beam Applications), Varian (Siemens Healthineers), Hitachi Medical Systems, Mevion Medical Systems and Sumitomo Heavy Industries.
What is driving the Proton Therapy market?
Rising cancer cases, earlier detection, precision medicine and a strong pipeline of targeted and immune therapies are driving the proton Therapy market. Faster approvals and new combinations are improving survival.
Who regulates Proton Therapy in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Proton Therapy are running in Europe?
38 studies are recruiting, active or about to start in Europe, counted across the 6 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Proton Therapy?
PubMed lists 3,474 papers on Proton Therapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.